Insiders who reported open-market trades in the last 12 months at the companies John A. Roush files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
George W. Lemaitre - $27.08M in LMAT purchases and sales in the last 12 months
David B. Roberts - $1.26M in LMAT purchases and sales in the last 12 months
Trent G. Kamke - $713K in LMAT purchases and sales in the last 12 months
Bridget A. Ross - $560K in LMAT purchases and sales in the last 12 months
John A. Roush is a corporate insider, tracked as Director of LEMAITRE VASCULAR INC (LMAT). InsiderAlpha holds 17 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John A. Roush submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has John A. Roush been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($4.00M) across all tracked filings.
John A. Roush is Director of LEMAITRE VASCULAR INC (LMAT). 17 SEC Form 4 filings on record going back to 2024, most recently on 8 September 2026. Most recent open-market trade: sold $98K of AEIS on 6 March 2026. Lifetime open-market sales: $4.00M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by John A. Roush.
InsiderAlpha's records for John A. Roush go back to 2024: 17 primary Form 4 filings, an average of 5.7 per year. 7 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
